Table 2

Summary of subscale responses

NEI VFQ-25 SubscaleAll BRVO patientsReference groupDiabetic retinopathyCRVOAMDLV
N=46N=22p ValueN=123p ValueN=51p ValueN=108p ValueN=90p Value
General health61.4(20.9)69(24)0.04746(25)<0.00151(29)0.04465(25)0.35957(27)0.296
General vision67.8(15.5)83(15)<0.00162(21)0.05358(23)0.01553(20)<0.00138(18)<0.001
Near vision72.8(18.9)92(13)<0.00163(30)0.01362(32)0.04454(27)<0.00136(23)<0.001
Distance vision77.2(18.8)93(11)<0.00166(30)0.00467(28)0.03656(29)<0.00138(26)<0.001
Driving75.3(23.6)87(18)0.00355(40)<0.00150(39)<0.00139(36)<0.00110(23)<0.001
Peripheral vision83.2(20.4)97(10)<0.00178(29)0.19565(27)<0.00177(27)0.12259(32)<0.001
Colour vision96.7(12.5)98(8)0.51490(22)0.01580(30)0.00185(25)<0.00171(31)<0.001
Ocular pain76.6(20.2)90(5)<0.00188(17)0.00185(18)0.03487(16)0.00385(20)0.024
Role difficulties75.0(27.0)93(13)<0.00169(31)0.22163(32)0.04861(31)0.00644(29)<0.001
Dependency91.7(19.1)99(6)0.01477(30)<0.00169(34)<0.00172(30)<0.00151(31)<0.001
Social functioning94.0(12.8)99(3)0.01281(26)<0.00170(30)<0.00173(29)<0.00150(31)<0.001
Mental health73.8(20.9)92(12)<0.00166(29)0.05660(28)0.00758(27)<0.00146(27)<0.001
  • p Values are based on a t test comparison with the branch retinal vein occlusion (BRVO) group. Data are given as mean (SD).

  • AMD, age-related macular degeneration; CRVO, central vein occlusion; LV, low vision; NEI VFQ-25, National Eye Institute 25-Item Visual Function Questionnaire.